Cell and Gene Therapy Today—July 2, 2026
This week’s Gene and Cell Therapy update highlights regulatory progress,…
Lucid Diligence Brief: Bayer to Acquire Perfuse Therapeutics for Up to $2.45B
Lucid Diligence Brief: Bayer to Acquire Perfuse Therapeutics for Up to $2.45B…
Endocrinology Today—April 7, 2026
This week’s Endocrinology update highlights care delivery innovation, broader…
Endocrinology Today—November 18, 2025
Weekly Endocrinology update spotilighting regulatory developments, clinical…
EURETINA 2025 Preview: Key Retinal Disease Highlights to Watch
EURETINA 2025 at a glance Looking ahead to EURETINA 2025, LucidQuest outlines…